Time to steroids impacts visual outcome ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Time to steroids impacts visual outcome of optic neuritis in MOGAD
Auteur(s) :
Rode, Julie [Auteur]
Neurologie, maladies neuro-musculaires [Hôpital de la Timone - APHM]
Pique, J. [Auteur]
Maarouf, A. [Auteur]
Ayrignac, X. [Auteur]
Bourre, B. [Auteur]
Ciron, J. [Auteur]
Cohen, M. [Auteur]
Collongues, N. [Auteur]
Deschamps, R. [Auteur]
Maillart, E. [Auteur]
Montcuquet, A. [Auteur]
Papeix, C. [Auteur]
Ruet, A. [Auteur]
Wiertlewski, S. [Auteur]
Zephir, Helene [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Marignier, R. [Auteur]
Audoin, B. [Auteur]
Neurologie, maladies neuro-musculaires [Hôpital de la Timone - APHM]
Pique, J. [Auteur]
Maarouf, A. [Auteur]
Ayrignac, X. [Auteur]
Bourre, B. [Auteur]
Ciron, J. [Auteur]
Cohen, M. [Auteur]
Collongues, N. [Auteur]
Deschamps, R. [Auteur]
Maillart, E. [Auteur]
Montcuquet, A. [Auteur]
Papeix, C. [Auteur]
Ruet, A. [Auteur]
Wiertlewski, S. [Auteur]
Zephir, Helene [Auteur]
Lille Neurosciences & Cognition (LilNCog) - U 1172
Marignier, R. [Auteur]
Audoin, B. [Auteur]
Titre de la revue :
Journal of Neurology, Neurosurgery and Psychiatry
Numéro :
94
Pagination :
309-313
Éditeur :
BMJ Journals
Date de publication :
2023-02-28
ISSN :
0022-3050
Mot(s)-clé(s) :
NEUROOPHTHALMOLOGY
NEUROIMMUNOLOGY
VISION
CLINICAL NEUROLOGY
NEUROIMMUNOLOGY
VISION
CLINICAL NEUROLOGY
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Background To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Methods We searched the French MOGAD database ...
Lire la suite >Background To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Methods We searched the French MOGAD database for adults with inaugural ON with a detailed report of acute treatment modalities and measures of high-contrast best-corrected visual acuity (BCVA) at nadir and after 3 months. Predictors of visual outcomes were assessed by multivariable analysis. Results Among 245 patients with at least one episode of ON, 82 fulfilled all criteria, and data on the peripapillary retinal nerve fibre layer (pRNFL) were available for 44. All patients received methylprednisolone (MP), combined with plasma exchange in 18. After 3 months, 75 of 82 (91%) patients retained full BCVA recovery, and median (range) pRNFL of the affected eye was 72 µm (40–102). Failure to regain 0.0 logarithmic minimum angle of resolution vision (Snellen 20/20) at 3 months was associated with time to first MP treatment ≥10 days (OR 16, 95% CI 1.14 to 213, p=0.01). pRNFL thickness after 3 months was related to better BCVA at nadir and time to first MP treatment <10 days (r2=19%, p=0.004 and r2=11%, p=0.03, respectively). Conclusions Time to MP affects functional but also structural visual outcomes of ON in MOGAD.Lire moins >
Lire la suite >Background To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Methods We searched the French MOGAD database for adults with inaugural ON with a detailed report of acute treatment modalities and measures of high-contrast best-corrected visual acuity (BCVA) at nadir and after 3 months. Predictors of visual outcomes were assessed by multivariable analysis. Results Among 245 patients with at least one episode of ON, 82 fulfilled all criteria, and data on the peripapillary retinal nerve fibre layer (pRNFL) were available for 44. All patients received methylprednisolone (MP), combined with plasma exchange in 18. After 3 months, 75 of 82 (91%) patients retained full BCVA recovery, and median (range) pRNFL of the affected eye was 72 µm (40–102). Failure to regain 0.0 logarithmic minimum angle of resolution vision (Snellen 20/20) at 3 months was associated with time to first MP treatment ≥10 days (OR 16, 95% CI 1.14 to 213, p=0.01). pRNFL thickness after 3 months was related to better BCVA at nadir and time to first MP treatment <10 days (r2=19%, p=0.004 and r2=11%, p=0.03, respectively). Conclusions Time to MP affects functional but also structural visual outcomes of ON in MOGAD.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Collections :
Date de dépôt :
2024-01-15T23:56:12Z
2024-07-03T07:59:05Z
2024-07-03T07:59:05Z